Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04637009
Title A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama - Birmingham Comprehensive Cancer Center Birmingham Alabama 35233 United States Details
HonorHealth Research Institute Scottsdale Arizona 82528 United States Details
University of Southern California Keck School of Medicine Los Angeles California 90033 United States Details
Augusta University - Georgia Cancer Center Augusta Georgia 30912 United States Details
Norton Cancer Institute Louisville Kentucky 40241 United States Details
Weill Cornell Medicine and New York - Presbyterian Hospital New York New York 10065 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Alberta Hospital - Hematology Research Edmonton Alberta T6G 2V2 Canada Details
Princess Margaret Hospital Toronto Ontario M5G 2L7 Canada Details
*Shaded cells indicate that there was no data available from for the field